Expansion of clinical trial opportunities through OneOncology for genomic based treatments
ECHO proudly enrolled the first patients in two genomic based studies ( MYTACTIC and KRYSTAL-7) opened within the OneOncology network. This demonstrates that innovative genomic testing affords patients the opportunity to be treated in their own community with personalized, targeted therapy.
Below is a helpful article from Dana Farber that describes why genomic research is the future of oncology care. ECHO is proud to be part of this journey.